Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2014
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activityHerbert J Zeh, Stephanie Downs-Canner, J Andrea McCart, et al.
The Journal of Clinical Investigation|September 11, 2018
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockadeJoy Hsu, Jonathan J Hodgins, Malvika Marathe, et al.
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, et al.
Nature Medicine|February 12, 2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerJeong Heo, Tony Reid, Leyo Ruo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entryTaha Azad, Ragunath Singaravelu, Zaid Taha, et al.
Nature|September 3, 2011
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansCaroline J Breitbach, James Burke, Derek Jonker, et al.
Nature Communications|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapiesTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
American Journal of Respiratory Cell and Molecular Biology|October 22, 2025
Design and Characterization of 4D-710, an Aerosolized Gene Therapy for Cystic Fibrosis Lung DiseaseMelissa A Calton, Roxanne H Croze, Theodore H Sullivan, et al.
Pageof 22